Litcius/Paper detail

Molecular immune pathogenesis and diagnosis of COVID-19

Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu

2020Journal of Pharmaceutical Analysis1,759 citationsDOIOpen Access PDF

Abstract

Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.

Topics & Concepts

Middle East respiratory syndrome coronavirusCoronavirusPathogenesisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PneumoniaCoronavirus disease 2019 (COVID-19)Immune systemVirologyDiseasePopulationImmunologyAtypical pneumoniaSevere acute respiratory syndromeBetacoronavirusMedicineInfectious disease (medical specialty)PathologyEnvironmental healthInternal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies
Molecular immune pathogenesis and diagnosis of COVID-19 | Litcius